View More View Less
  • 1 Krankenhaus Barmherzige Brüder, Regensburg, Németország
  • 2 Petz Aladár Megyei Oktató Kórház, Győr
  • 3 Pécsi Tudományegyetem, Általános Orvostudományi Kar, Pécs
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

Absztrakt

A chylothorax napjainkban rendszerint műtéti vagy baleseti szövődmény, ritkábban daganat következménye. Prospektív vagy randomizált vizsgálatok hiányában a bizonyítékalapú kezelés személyes tapasztalaton, ideálisan a retrospektív elemzések ismeretében történik. A szerzők célja a chylothorax modern kezelésének áttekintése. A PubMed adatbázist „chylothorax” kulcsszóra szűrték az elmúlt tíz év közleményei között, kiemelve az összehasonlító értékeléseket. A módszerek és ajánlások kritikai elemzésekor a szerzők együttes 39 éves klinikai tapasztalatukra támaszkodtak. A konzervatív kezelés sikere az etiológiától függően nagy szórást mutat (3–90%). A non- és szemi-invazív intervenciós eljárások sikerrátája 50–100% közötti. Eredménytelen konzervatív kezeléskor a sebészi kezelés, elsősorban a ductus thoracicus lekötése jelenti a standard terápiát. Ezen beavatkozások sikerességi aránya 64–100% közötti, a morbiditási/mortalitási mutató elérheti a 25%-ot. A kezelést konzervatívan kell megkezdeni, majd egy lépcsőzetes agresszivitású terápia ajánlott, amelyben a beteg állapota és a drénvolumen irányítják a döntéshozatalt. Az intervenciós radiológiai eljárások biztonságosak, sikeresek és helyet kaptak a konzervatív és műtéti megoldások mellett. Orv. Hetil., 2016, 157(2), 43–51.

  • 1

    McGrath, E. E., Blades, Z., Anderson, P. B.: Chylothorax: aetiology, diagnosis and therapeutic options. Respir. Med., 2010, 104(1), 1–8.

  • 2

    Doerr, C. H., Allen, M. S., Nichols, F. C. 3rd, et al.: Etiology of chylothorax in 203 patients. Mayo Clin. Proc., 2005, 80(7), 867–870.

  • 3

    Narayan, P., Rahaman, N., Molnar, T. F., et al.: Chylothorax following cardiac surgery caused by unusual lymphatic anatomy. Asian Cardiovasc. Thorac. Ann., 2007, 15(5), e58–e59.

  • 4

    Sziklavari, Z., Allgäuer, M., Hübner, G., et al.: Radiotherapy in the treatment of postoperative chylothorax. J. Cardiothorac. Surg., 2013, 8, 72.

  • 5

    Chalret du Rieu, M., Baulieux, J., Rode, A., et al.: Management of postoperative chylothorax. J. Visc. Surg., 2011, 148(5), e346–e352.

  • 6

    Kaul, T. K., Bain, W. H., Turner, M. A., et al.: Chylothorax: report of a case complicating ductus ligation through a median sternotomy, and review. Thorax, 1976, 31(5), 610–616.

  • 7

    Phang, K., Bowman, M., Phillips, A., et al.: Review of thoracic duct anatomical variations and clinical implications. Clin. Anat., 2014, 27(4), 637–644.

  • 8

    Takuwa, T., Yoshida, J., Ono, S., et al.: Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J. Thorac. Cardiovasc. Surg., 2013, 146(3), 571–574.

  • 9

    Chen, E., Itkin, M.: Thoracic duct embolization for chylous leaks. Semin. Intervent. Radiol., 2011, 28(1), 63–74.

  • 10

    Lyon, S., Mott, N., Koukounaras, J., et al.: Role of interventional radiology in the management of chylothorax: a review of the current management of high output chylothorax. Cardiovasc. Intervent. Radiol., 2013, 36(3), 599–607.

  • 11

    Bryant, A. S., Minnich, D. J., Wei, B., et al.: The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection. Ann. Thorac. Surg., 2014, 98(1), 232–235.

  • 12

    Kunitoh, H., Kato, H., Tsuboi, M., et al.: Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J. Clin. Oncol., 2008, 26(4), 644–649.

  • 13

    Light, R. W.: Pleural effusions. Med. Clin. North Am., 2011, 95(6), 1055–1070.

  • 14

    Rustico, M. A., Lanna, M., Coviello, D., et al.: Fetal pleural effusion. Prenat. Diagn., 2007, 27(9), 793–799.

  • 15

    Yekeler, E., Ulutas, H.: Bilateral chylothorax after severe vomiting in a child. Ann. Thorac. Surg., 2012, 94(1), e21–e23.

  • 16

    Miller, J. I. Jr.: Anatomy of the thoracic duct and chylothorax. In: Shields, T. W., LoCicero, J. 3rd, Ponn, R. B., et al. (eds.): General thoracic surgery. 6th ed. Lippincott Williams & Wilkins, Philadelphia, 2005, 879–888.

  • 17

    Staats, B. A., Ellefson, R. D., Budahn, L. L., et al.: The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin. Proc., 1980, 55(11), 700–704.

  • 18

    Maldonado, F., Hawkins, F. J., Daniels, C. E., et al.: Pleural fluid characteristics of chylothorax. Mayo Clin. Proc., 2009, 84(2), 129–133.

  • 19

    Sassoon, C. S., Light, R. W.: Chylothorax and pseudochylothorax. Clin. Chest Med., 1985, 6(1), 163–171.

  • 20

    Skouras, V., Kalomenidis, I.: Chylothorax: diagnostic approach. Curr. Opin. Pulm. Med., 2010, 16(4), 387–393.

  • 21

    Huggins, J. T.: Chylothorax and cholesterol pleural effusion. Semin. Respir. Crit. Care Med., 2010, 31(6), 743–750.

  • 22

    Benedix, F., Lippert, H., Meyer, F.: Etiology, diagnosis and treatment of lymphocutaneous fistulas, chylascites and chylothorax as infrequent but serious complications following surgical procedures. Zentralbl. Chir., 2012, 137(6), 580–586.

  • 23

    Sziklavari, Z., Neu, R., Hofmann, H. S., et al.: Persistent pleural effusion following thoracic surgery. Chirurg, 2015, 86(5), 432–436.

  • 24

    Wasmuth-Pietzuch, A., Hansmann, M., Bartmann, P., et al.: Congenital chylothorax: lymphopenia and high risk of neonatal infections. Acta Paediatr., 2004, 93(2), 220–224.

  • 25

    Breaux, J., Marks, C.: Chylothorax causing reversible T-cell depletion. J. Trauma, 1988, 28(5), 705–707.

  • 26

    Hölscher, A. H., Fetzner, U. K., Bludau, M., et al.: Complications and management of complications in oesophageal surgery. Zentralbl. Chir., 2011, 136(3), 213–223.

  • 27

    Shah, R. D., Luketich, J. D., Schuchert, M. J., et al.: Postesophagectomy chylothorax: Incidence, risk factors, and outcomes. Ann. Thorac. Surg., 2012, 93(3), 897–904.

  • 28

    Bessone, L. N., Ferguson, T. B., Burford, T. H.: Chylothorax. Ann. Thorac. Surg., 1971, 12(5), 527–550.

  • 29

    Guo, W., Zhao, Y. P., Jiang, Y. G., et al.: Prevention of postoperative chylothorax with thoracic duct ligation during video-assisted thoracoscopic esophagectomy for cancer. Surg. Endosc., 2012, 26(5), 1332–1336.

  • 30

    Nair, S. K., Petko, M., Hayward, M. P.: Aetiology and management of chylothorax in adults. Eur. J. Cardiothorac. Surg., 2007, 32(2), 362–369.

  • 31

    DePew, Z. S., Iqbal, S., Mullon, J. J., et al.: The role for tunneled indwelling pleural catheters in patients with persistent benign chylothorax. Am. J. Med. Sci., 2013, 346(5), 349–352.

  • 32

    Zabeck, H., Muley, T., Dienemann, H., et al.: Management of chylothorax in adults: when is surgery indicated? Thorac. Cardiovasc. Surg., 2011, 59(4), 243–246.

  • 33

    Cerfolio, R. J., Allen, M. S., Deschamps, C., et al.: Postoperative chylothorax. J. Thorac. Cariovasc. Surg., 1996, 112(5), 1361–1365.

  • 34

    Shimizu, K., Yoshida, J., Nishimura, M., et al.: Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J. Thorac. Cardiovasc. Surg., 2002, 124(3), 499–502.

  • 35

    Fujita, T., Daiko, H.: Efficacy and predictor of octreotide treatment for postoperative chylothorax after thoracic esophagectomy. World J. Surg., 2014, 38(8), 2039–2045.

  • 36

    Cho, H. J., Kim, D. K., Lee, G. D., et al.: Chylothorax complicating pulmonary resection for lung cancer: effective management and pleurodesis. Ann. Thorac. Surg., 2014, 97(2), 408–413.

  • 37

    Maldonado, F., Cartin-Ceba, R., Hawkins, F. J., et al.: Medical and surgical management of chylothorax and associated outcomes. Am. J. Med. Sci., 2010, 339(4), 314–318.

  • 38

    Das, A., Shah, P. S.: Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst. Rev., 2010, 8(9), CD006388.

  • 39

    Bello, S. O., Rahamim, J.: High-dose intravenous octreotide is safe and may be superior to surgery in managing severe postesophagectomy chylothorax in high-risk patients. Ann. Thorac. Surg., 2015, 100(1), 297–299.

  • 40

    Cannizzaro, V., Frey, B., Bernet-Buettiker, V.: The role of somatostatin in the treatment of persistent chylothorax in children. Eur. J. Cardiothorac. Surg., 2006, 30(1), 49–53.

  • 41

    Roehr, C. C., Jung, A., Proquitté, H., et al.: Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med., 2006, 32(5), 650–657.

  • 42

    Sharkey, A. J., Rao, J. N.: The successful use of octreotide in the treatment of traumatic chylothorax. Tex. Heart Inst. J., 2012, 39(3), 428–430.

  • 43

    Lim, K. A., Kim, S. H., Huh, J., et al.: Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease. J. Korean Med. Sci., 2005, 20(6), 947–951.

  • 44

    O’Callaghan, A. M., Mead, G. M.: Chylothorax in lymphoma: mechanisms and management. Ann. Oncol., 1995, 6(6), 603–607.

  • 45

    Teng, C. L., Li, K. W., Yu, J. T., et al.: Malignancy-associated chylothorax: a 20-year study of 18 patients from a single institution. Eur. J. Cancer Care, 2012, 21(5), 599–605.

  • 46

    Larsen, S., Manoharan, A., Fermanis, G., et al.: An unusual case of chylothorax complicating non-Hodgkin’s lymphoma. Leuk. Lymphoma, 2000, 38(1–2), 207–209.

  • 47

    Dietl, B., Pfister, K., Aufschläger, C., et al.: Radiotherapy of inguinal lymphorrhea after vascular surgery. A retrospective analysis. Strahlenther. Onkol., 2005, 181(6), 396–400.

  • 48

    Gómez-Caro, A. A., Moradiellos Diez, F. J., Marrón, C. F., et al.: Conservative management of postsurgical chylothorax with octreotide. Asian Cardiovasc. Thorac. Ann., 2005, 13(3), 222–224.

  • 49

    Collard, J. M., Laterre, P. F., Boemer, F., et al.: Conservative treatment of postsurgical lymphatic leaks with somatostatin-14. Chest, 2000, 117(3), 902–905.

  • 50

    Pui, M. H., Yueh, T. C.: Lymphoscintigraphy in chyluria, chyloperitoneum and chylothorax. J. Nucl. Med., 1998, 39(7), 1292–1296.

  • 51

    Yu, D. X., Ma, X. X., Wang, Q., et al.: Morphological changes of the thoracic duct and accessory lymphatic channels in patients with chylothorax: detection with unenhanced magnetic resonance imaging. Eur. Radiol., 2013, 23(3), 702–711.

  • 52

    Lutz, P., Strunk, H., Schild, H. H., et al.: Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis. World J. Gastroenterol., 2013, 19(7), 1140–1142.

  • 53

    Itkin, M., Kucharczuk, J. C., Kwak, A., et al.: Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J. Thorac. Cardiovasc. Surg., 2010, 139(3), 584–589.

  • 54

    Akin, H., Olcmen, A., Isgorucu, O., et al.: Approach to patients with chylothorax complicating pulmonary resection. Thorac. Cardiovasc. Surg., 2012, 60(2), 135–139.

  • 55

    Paul, S., Altorki, N. K., Port, J. L., et al.: Surgical management of chylothorax. Thorac. Cardiovasc. Surg., 2009, 57(4), 226–228.

  • 56

    Schoellnast, H., Maybody, M. Getrajdman, G. I., et al.: Computed tomography-guided access to the cisterna chyli: introduction of a technique for direct lymphangiography to evaluate and treat chylothorax. Cardiovasc. Intervent. Radiol., 2011, 34(Suppl. 2), S240–S244.

  • 57

    Alejandre-Lafont, E., Krompiec, C., Rau, W. S., et al.: Effectiveness of therapeutic lymphography on lymphatic leakage. Acta Radiol., 2011, 52(3), 305–311.

  • 58

    Cope, C., Salem, R., Kaiser, L. R.: Management of chylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J. Vasc. Interv. Radiol., 1999, 10(9), 1248–1254.

  • 59

    Cope, C., Kaiser, L.: Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J. Vasc. Interv. Radiol., 2002, 13(11), 1139–1148.

  • 60

    Nadolski, G. J., Itkin, M.: Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Chest, 2013, 143(1), 158–163.

  • 61

    Boffa, D. J., Sands, M. J., Rice, T. W., et al.: A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur. J. Cardiothorac. Surg., 2008, 33(3), 435–439.

  • 62

    Lee, E. W., Shin, J. H., Ko, H. K., et al.: Lymphangiography to treat postoperative lymphatic leakage: a technical review. Korean J. Radiol., 2014, 15(6), 724–732.

  • 63

    Gaba, R. C., Owens, C. A., Bui, J. T., et al.: Chylous ascites: a rare complication of thoracic duct embolization for chylothorax. Cardiovasc. Intervent. Radiol., 2011, 34(2), 245–249.

  • 64

    Binkert, C. A., Yucel, K., Davison, B. D., et al.: Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J. Vasc. Interv. Radiol., 2005, 16(9), 1257–1262.

  • 65

    Litherland, B., Given, M., Lyon, S.: Percutaneous radiological management of high output chylothorax with CT-guided needle disruption. J. Med. Imaging Radiat. Oncol., 2008, 52(2), 164–167.

  • 66

    Bölükbas, S., Kudelin, N., Dönges, T., et al.: Therapy management of chylothorax. Chirurg, 2010, 81(3), 255–263.

  • 67

    Laslett, D., Trerotola, S. C., Itkin, M.: Delayed complications following technically successful thoracic duct embolization. J. Vasc. Interv. Radiol., 2012, 23(1), 76–79.

  • 68

    Orringer, M. B., Bluett, M., Deeb, G. M.: Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy. Surgery, 1988, 104(4), 720–726.

  • 69

    Alexiou, C., Watson, M., Beggs, D., et al.: Chylothorax following oesophagogastrectomy for malignant disease. Eur. J. Cardiothorac. Surg., 1998, 14(5), 460–466.

  • 70

    Ryu, J. H., Tomassetti, S., Maldonado, F.: Update on uncommon pleural effusions. Respirology, 2011, 16(2), 238–243.

  • 71

    Sahn, S. A.: Management of malignant pleural effusions. Monaldi Arch. Chest Dis., 2001, 56(5), 394–399.

  • 72

    Gupta, D., Ross, K., Piacentino, V. 3rd, et al.: Use of LeVeen pleuroperitoneal shunt for refractory high-volume chylothorax. Ann. Thorac. Surg., 2004, 78(1), e9–e12.

  • 73

    Akaogi, E., Mitsui, K., Sohara, Y., et al.: Treatment of postoperative chylothorax with intrapleural fibrin glue. Ann. Thorac. Surg., 1989, 48(1), 116–118.